Status:

RECRUITING

Induction Chemotherapy for Locally Recurrent Rectal Cancer

Lead Sponsor:

Catharina Ziekenhuis Eindhoven

Conditions:

Recurrent Rectal Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a multicentre, open-label, parallel arms, phase IIII study that randomises patients with locally recurrent rectal cancer in a 1:1 ratio to receive either induction chemotherapy followed by neo...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Confirmed locally recurrent rectal cancer after total or partial mesorectal resection for rectal or distal sigmoidal cancer either by histopathology ór clinically proven (evidence on imaging in combination with clinical findings, with consensus in MDT)
  • Resectable disease determined by magnetic resonance imaging (MRI) or deemed resectable after neoadjuvant treatment with chemoradiotherapy.
  • WHO performance score 0-1
  • Written informed consent

Exclusion

  • Radiological evidence of metastatic disease (e.g. liver, lung) at time of randomisation or in the six months prior to randomisation.
  • Known homozygous DPD deficiency
  • Any chemotherapy in the past 6 months.
  • Any contraindication for the planned chemotherapy, as determined by the medical oncologist.
  • Radiotherapy in the past 6 months for primary rectal cancer.
  • Any contraindication for the planned chemoradiotherapy, as determined by the medical oncologist and/or radiation oncologist.
  • Any contraindication for surgery, as determined by the surgeon and/or anaesthesiologist.
  • Concurrent malignancies that interfere with the planned study treatment or the prognosis of resected LRRC.

Key Trial Info

Start Date :

November 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2030

Estimated Enrollment :

364 Patients enrolled

Trial Details

Trial ID

NCT04389086

Start Date

November 13 2020

End Date

March 1 2030

Last Update

September 6 2022

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

UZ Gent

Ghent, Belgium

2

Amsterdam UMC

Amsterdam, Netherlands

3

Antoni van Leeuwenhoek

Amsterdam, Netherlands

4

Catharina Hospital

Eindhoven, Netherlands, 5623EJ